Figure 6.

First approval dates of imported new anticancer drugs in the US and China. Red circles, black solid circles, and black X marks denote anticancer drugs granted Priority Review (PR), Conditional Approval (CA), and Special Review (SR) designations, respectively. Green squares indicate new drugs that were on the lists of Urgently Needed Overseas Drugs (UNOD) released since Nov 2018. Black triangles denote the drug approvals undergoing non-designated procedures. The diagonal solid line represents the same day of approval in the U.S. and China. The fitted line in blue with 95% confidence interval based on the locally weighted scatterplot smoothing (LOWESS) approach indicates the tendency of drug lag. The line approaching the diagonal line means the shortened drug lag.